Furthermore, glioma cells become more sensitive to Taxol, temozolomide, and doxorubicin after the IGF2BP3 gene is knocked down, suggesting a role for IGF2BP3 in chemotherapy resistance [75]. Here, IGF2BP3 is linked to central nervous system cancer.